Measurement of energy expenditure (EE) in both healthy individuals and different groups of patients is fundamental in the establishment of accurate estimates of energy requirements in both health and disease, and also provides an insight into the mechanism of the wasting process associated with disease (Nelson et al. 1994; Elia, 1995) . Such information is clinically useful for the prescription of energy and protein nutrition, both of which aim to avoid the detrimental effects of overfeeding and underfeeding McClave et al. 1998) .
Total EE (TEE) in its simplest form is comprised of three components, the sum of which determines the energy requirement for any individual:
1. BMR; 2. thermogenesis, usually dietary-induced thermogenesis (DIT); 3. physical activity (PA). Previously, energy requirements in disease had been thought to be elevated due to a measured increase in BMR often observed with disease. Estimates of EE and energy intake provided by different health organizations (Department of Health, 1991) are usually given as a multiple of BMR, either measured using indirect calorimetry or estimated using standard equations (Schofield et al. 1985) . However, prediction of TEE from BMR is liable to errors, particularly when BMR is elevated. The use of tracer techniques have shown that even when BMR is increased TEE can actually be reduced (Goran et al. 1994; Gibney et al. 1996) due to a concurrent reduction in PA (Fig. 1) . Since the energy cost of PA is the most variable component of TEE, and is affected in many different ways by various diseases, TEE in clinical practice can be very variable. control, although they are known to influence BMR. As true measurements of BMR may be difficult to obtain, an alternative, i.e. resting metabolic rate (RMR), can be measured more easily, e.g. in the fed state, after drug administration or blood transfusion. It is important to note however that BMR and RMR differ by about 10-15 % (Garrow & James, 1993) .
In disease BMR can deviate from normal for a number of reasons (Table 2) , many of which are difficult to avoid. Berke et al. (1992) showed that even pretesting conditions had an effect on subsequent measurements of metabolic rate. They demonstrated that when measurements of RMR were taken under 'out patient' conditions (i.e. when individuals made their way to the test centre on the morning of the measurement), measurements of RMR were overestimated by an average of 8 %.
It is well known that ingestion of food can cause an increase in basal metabolism (Romon et al. 1993; Reed & Hill, 1996) . The term 'DIT' encompasses the full physical response to the ingestion of food (Garrow & James, 1993) . DIT is typically assumed to correspond to approximately 10 % of the energy content of a normal meal or 10 % of TEE in a weight-stable individual. Often, in clinical situations patients are maintained on strict dietary regimens, including parenteral or enteral feeding (24 h, overnight and bolus regimens). Measurements taken without proper interruption of feeding for an appropriate length of time will give a misleadingly high estimation of BMR which could be misinterpreted as being due to the hypermetabolism of disease.
Drugs can produce either an increase or a decrease in BMR and/or PA (Demark-Wahnefried et al. 1997; Diffey et al. 1997) . Dempsey et al. (1985) investigated the effect of sedative dosage on EE in critically-ill ventilated patients. They found that as the dosage of sedative increased, EE decreased, with some individuals reaching only 60 % of predicted EE on the high doses of sedative. The same conclusion was drawn by Fried et al. (1989) , who also showed a significant (P < 0·05) decrease in measured EE in their sedated group.
It is a well documented fact that BMR, even in healthy individuals, can vary throughout the course of the day (Cunningham, 1980; Soares & Shetty, 1986) . It is also important to note that BMR can vary not only during the day, but also considerably from day-to-day, especially in the early phases of infectious disease and trauma. Cuthbertson's (1942) classic work during the 1940s described the ebb and flow phases of injury, and the associated changes in O 2 consumption. He noted that after an initial decrease in O 2 consumption (ebb phase) individuals showed a marked increase in O 2 consumption (flow phase) which slowly returned to normal. More recently, Young et al. (1985) assessed repeated measurements of BMR in hospitalized patients suffering from severe trauma. Measurements of metabolic rate were initially found to be 1·5 times that of predicted BMR, only returning to approximately normal levels at 22 d after the initial trauma.
If recommendations for energy requirements are to be based on measurements of BMR, then when should the measurements be made? If a measurement is taken at the peak of metabolism, and recommendations of energy intake are based on this measurement, then for the majority of the duration of the trauma, an individual will receive an energy intake that is in excess of requirements. Conversely, if a measurement is taken at a point of reduced metabolism, then an individual may become more malnourished during the course of the illness. What must be stressed is the need to estimate the provision of energy requirements over a period of time. In essence, what we really need to know is the (Gibney et al. 1996) compared with recommended values (Department of Health, 1991;  Table 5 ). (1), BMR; (]), dietaryinduced thermogenesis; (k), physical activity. BMR was significantly increased (P < 0·05) and TEE significantly reduced (P < 0·05) in patients with lung cancer compared with recommended values for healthy subjects. Measurements of total energy expenditure TEE can be measured using a number of different methods (for review, see Murgatroyd et al. 1993 ):
1. 24 h respiratory gas exchange (indirect calorimetry); 2. doubly-labelled water; 3. bicarbonate-urea method; 4. heart-rate monitoring.
Indirect calorimetry
Indirect calorimeters measure CO 2 production and O 2 consumption, which are used in the calculation of EE, in the context of TEE. To make full estimates of TEE using indirect calorimetry, subjects must be confined to a wholebody chamber to ensure a complete 24 h measurement. Measurements in such chambers give important information about EE under controlled conditions, but do not necessarily reproduce conditions in free-living circumstances. One circumstance in clinical practice, i.e. continuous ventilation in critically-ill patients, allows the measurement of 24 h TEE outside a respiratory chamber; details of such studies will be discussed later (p. 202).
Doubly-labelled water method
The doubly-labelled water method allows measurement of free-living TEE through oral administration of stable isotopes of water, 2 H 2 O and H 2 18 O (Lifson & McClintock, 1956; Coward, 1988) . The technique is based on the principle that after mixing with total body water, the 2 H is lost from the body only as water and the 18 O is lost both as water and CO 2 . Thus, the difference in the rates of loss of isotopes from the body is due to CO 2 production, from which an estimate of TEE can be made. The disappearance from the body is typically measured over two half-lives of the isotope, about 12-14 d in adults. Although the method is non-invasive and widely used, it only gives an average daily estimate of TEE over the 14 d period and is unable to assess day-to-day variation. Validation studies against whole-body indirect calorimetry have shown the method to be accurate to within a mean (SD 10 %) (Ravussin et al. 1991; Klein et al. 1984; Schoeller et al. 1986; Schoeller & Webb, 1984; Westerterp et al. 1988; Parkinson, 1990) .
Bicarbonate-urea method
The bicarbonate-urea method is a relatively novel method for measuring TEE in free-living human subjects. Like the doubly-labelled water technique it is essentially an isotopicdilution technique, measuring endogenous CO 2 production. Labelled CO 2 , given subcutaneously as H 14 CO 3 − , is diluted by the CO 2 produced in the body. The extent of this dilution, measured through the specific activity of urinary urea, allows the calculation of CO 2 production in the body. Using an appropriate value for the energy equivalent of CO 2 (Elia, 1991) , EE can then be estimated. Unlike the doubly-labelled water technique, the bicarbonate-urea method can make measurements over periods of 24 h, allowing the study of day-to-day variation in free-living conditions. Such day-today measurements may be important in a clinical setting as EE may vary from day-to-day during the course of a disease or trauma. This method has been validated in both healthy individuals and those with disease (Gibney et al. 1997b ; E Gibney, J Jennings, SA Jebb, PR Murgatroyd, A Wright and M Elia, unpublished results).
Heart-rate monitoring
Heart-rate monitoring is a simple and inexpensive method of measuring free-living TEE. There are a number of different heart-rate monitoring and recording devices that allow minute-to-minute recording of a heart rate over a set period of time. By measuring heart rate at different levels of PA and creating individual calibration curves, an estimation of EE can be made from such recordings of heart rate. This method has been extensively validated against a number of different methods (e.g. doubly-labelled water and indirect calorimetry) in both adults and children (Dauncey & James, 1979; Spurr et al. 1988; Ceesay et al. 1989 ). This method is not typically used in a disease population, as the physical limitations of the population group that inhibit the ability to obtain a proper calibration curve (bedridden, fatigue and injuries), and also the multiple clinical factors that affect heart rate.
Interpretation of measurements of total energy expenditure
The second part of the present review investigates the hypothesis, that, although an elevated BMR is seen in many disease situations, the increase in BMR is counteracted or more than counteracted by a decrease in PA. This hypothesis was examined by comparing results obtained in studies measuring energy expenditure in disease with values obtained in healthy individuals. The theory that energy requirements may in fact be reduced is in contrast with the physical wasting seen in disease, which may be due to a number of reasons, including negative energy balance (Hellerstein et al. 1990; Elia, 1995) , immobility (Deitrick et al. 1948) or high protein requirements compared with a standard diet ). The present paper, however, will only attempt to discuss the overall energy requirements, and does not investigate the macronutrient composition of any given diet.
Methods
All studies measuring free-living TEE in different inflammatory disease states were examined. These studies included those using the doubly-labelled water method, bicarbonate-urea method, heart-rate monitoring and indirect calorimetry. Studies that did not contain a true 24 h measurement of TEE and used only partial measurements as an estimate were excluded. Studies of stable congenital disease conditions (heart defects, ventricular septal defects, etc.) were also excluded. The following information was obtained from the literature review: age; weight; height; BMI; sample size; method of measurement of EE; duration of study; location of study; measured BMR; predicted BMR; TEE. Results from individual patients were included whenever possible, otherwise the group mean data was used. To allow for different comparisons, results were expressed in a number of different ways: TEE per kg; PA level; predicted PA level (Schofield et al. 1985) ; energy expended in PA plus thermogenesis (PA + DIT); energy expended in PA + DIT per kg; energy expended in PA; energy expended in PA per kg; disease factor.
In studies where indirect calorimetry was carried out during feeding (resting EE) it was assumed that DIT was 10 % of the TEE. In studies where BMR was actually measured DIT was again assumed to be 10 % of the EE. The energy cost of PA was calculated as being equal to TEE − BMR − DIT. This calculation does not take into account thermogenesis due to other causes (e.g. drugs, coldness), but the value probably gives a good approximation of PA.
The data of Black et al. (1996) for measurements of EE, obtained using doubly-labelled water, were used to compare the results of TEE in disease with those of healthy individuals. Dietary reference values (Department of Health, 1991) were used for comparison with recommended intakes for healthy individuals. The studies were separated into two categories: those carried out in hospital; those carried out at home. Mean values for each study are given in Tables 3 and 4 with values for healthy individuals and recommended reference values shown in Table 5 .
Results
As hypothesized, many studies demonstrated a reduced TEE in comparison with reference values for healthy individuals. This reduction was evident in the study of Gibney et al. (1996) in patients with small-cell lung cancer (Fig. 1) . Whole-body indirect calorimetry indicated that values for BMR were significantly (P < 0·05) elevated in the lungcancer group by a mean of 6 % when compared with predicted values (Schofield et al. 1985) . These results are close to those found in a similar but larger group of patients (Jebb et al. 1994) . It is important to note, however, that TEE, measured under free-living conditions using the bicarbonate-urea technique in patients with lung cancer, was significantly reduced (8·9 MJ/d) compared with reference control values (9·6 MJ/d). Furthermore, PA accounted for 21 % of the TEE in the patients with cancer compared with 31 % in reference controls (Department of Health, 1991 ; P < 0·05). Such results apply to a variety of clinical conditions, demonstrated by the fact that TEE per kg was reduced in the majority of studies when compared with age-matched controls (see Table 5 ). Studies were conducted both in hospital (Table 4 ) and at home (Table 3) .
Measurement of EE in critically-ill patients is, as mentioned previously, of particular importance as energy intake is controlled by the clinician either through parenteral or enteral feeding (Weissman et al. 1986; Bruder et al. 1994) . Weekes & Elia (1996) measured 24 h EE by indirect calorimetry in critically-ill head-injured patients whilst they were being maintained on continuous ventilation. This study highlighted several interesting points. First, as there was very little voluntary movement in these individuals, EE was stable throughout the day, thus the measurement of TEE was similar if not equal to any measurement of RMR. This value was 35 % above BMR of study controls of the same age, weight and height, but irrespective of whether measurements of TEE were expressed in absolute terms, in relation to body weight or as multiples of BMR, TEE was reduced in this group. The results mirror those obtained by Pullicino (1991) in a similar cohort of patients. Second, Weekes & Elia (1996) demonstrated that EE decreased significantly (P < 0·05) as time progressed, returning to normal a full 12-19 d after initial injury.
Patients with burns are well known to be hypermetabolic as a result of the 'injury response' (heat loss across the damaged skin; Long et al. 1979; Goran et al. 1991) . Royall et al. (1994) measured EE in a group of twenty adults with severe burns (severe burn area > 30 %) whilst being maintained on continuous ventilation. Although RMR was 37 % higher than that in controls, PA was virtually nonexistent, which more than compensated for this substantial increase in RMR. This finding would then suggest that the energy requirement in this particular group should perhaps be reduced, even though an extremely high metabolic rate was recorded. Several formulas have been used to estimate energy requirements in these patients (Long, 1979; Wolfe, 1982; Cunningham et al. 1989; Goran et al. 1991) , with some equations prescribing up to 200 % of predicted BMR (Mildreth & Carvajal, 1982; Guzman et al. 1994) . In their study of stable patients with a severe burn area of 37 %, Royall et al. (1994) recommended that an activity factor of 20 % should be added to the measured resting EE to account for daily requirements. However, caution should be used in generally accepting this recommendation because of the considerable variability and changes over time in patients.
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TEE when compared with reference controls. These observations are consistent with a concurrent reduction in PA (Table 3) . Such results do not help to explain the characteristic weight loss seen in this disease, and would suggest that the answer may be a combination of disorders, as previously suggested (Hellerstein et al. 1990) .
Conclusions
The present paper confirms that EE is very variable in disease (Tables 3 and 4 ; Goran et al. 1985; Elia, 1995) . Such variations are partly due to variable effects of disease on BMR and PA, the presence of variable nutritional status (undernutrition tends to reduce predicted BMR) and inconsistent or inappropriate procedures for measuring and interpreting measurements of EE. What became evident in researching this topic is the lack of reporting of any such deviations, i.e. measurements being made whilst feeding, or under an unknown or unreported influence of drugs. Reporting such deviations and also reporting the timing of the measurement with respect to the trauma or disease stage would allow other observers to fully evaluate the results obtained, and allow proper comparisons from group-togroup. General recommendations are given in Table 6 . The appropriate use of tracer techniques and indirect calorimetry in a wider range of disease states would allow a greater understanding of the pathophysiology of wasting, and at the same time provide a better basis for recommendations as to the energy requirement in disease. It is important to affirm that measurements of EE in disease will only allow the clinician to assess the energy requirement of an individual with respect to the initial body composition of the Table 5 . Reference values for energy expenditure of healthy subjects (Black et al. 1996) 3·50  9·50  15·0  23·5  34·5  52·0  69·5  75·0   3·50  9·50  15·0  23·5  34·5  52·0  69·5  75·0   19·7  40·7  72·0  75·6  86·1  77·0  76·4  72·6   18·4  33·3  71·5  69·2  67·9  70·0  60·2  48·3   6·10  9·80  14·1  13·8  14·3  11·5  11·0  9·20   5·50  8·00  11·4  10·4  10·0  9·80  8·60  6·10   3·80  5·70  8·10  7·50  8·20  7·00  6·90  6·00   3·60  4·80  6·70  6·20  6·00  5·80  5·30  4·10   4·41  6·68  9·51  8·88  9·63  8·15  8·00  6·92   4·15  5·60  7·84  7·24  7·00  6·78  6·16  4·71   22·2  24·1  46·0  6·30  6·10  4·50  4·10  3·20   1·90  3·20  4·70  4·20  4·10  4·00  3·30  1·90   1·69  3·12  4·59  4·92  4·67  3·35  3·00  2·28   1·35  2·40  3·56  3·16  3·00  3·02  2·44  1·39   0·31  0·24  0·19  0·18  0·17  0·15  0·14  0·13   0·29  0·24  0·16  0·15  0·15  0·14  0·14  0·13   0·09  0·08  0·06  0·07  0·05  0·04  0·03  0·03   0·07  0·07  0·05  0·05  0·04  0·04  0·04  0·03   0·11  0·10  0·08  0·07  0·06  0·05  0·04 2·00  5·00  8·50  12·5  16·5  34·0  54·5  62·0  69·5  75·0   2·00  5·00  8·50  12·5  16·5  34·0  54·5  62·0  69·5  75·0   12·4  19·3  28·3  40·5  62·5  74·0  74·0  74·0  71·0  69·0   11·8  18·9  28·2  43·0  56·5  60·0  63·0  63·5  63·0  60·0   5·15  7·16  8·24  9·27  11·5  11·5  11·5  9·93  9·50  9·34   4·86  6·46  7·28  7·92  8·83  8·93  9·09  9·10  8·24  8·06   2·96  3·94  4·79  5·94  6·94  7·21  7·21  7·21  5·94  5·84   2·75  3·64  4·43  5·32  6·07  5·58  5·68  5·69  5·15  5·04   3·48  4·66  5·61  6·87  8·09  8·36  8·36  8·36  6·89  6·77   3·24  4·29  5·21  6·11  6·95  6·47  6·59  6·60  5·97  5·85   2·19  3·22  3·45  3·33  4·57  4·32  4·32  4·32  3·56  3·50   2·11  2·82  2·85  2·61  2·77  3·35  3·41  3·14  3·09  3·02   1·67  2·50  2·63  2·40  3·42  3·17  3·17  3·17  2·61  2·57   1·62  2·17  2·07  1·89  1·88  2·46  2·50  2·50  2·27  2·24   0·42  0·37  0·29  0·14  0·13  0·16  0·16  0·16  0·14  0·13   0·41  0·34  0·26  0·18  0·16  0·15  0·14  0·14  0·14  0·13   0·14  0·13  0·09  0·06  0·05  0·04  0·04  0·04  0·04  0·03   0·14  0·12  0·08  0·03  0·02  0·04  0·04  0·04  0·04  0·04   0·18  0·17  0·12  0·08  0·07  0·06  0·06  0·06  0·05  0·05   0·18  0·15  0·10  0·06  0·05  0·06  0·05  0·05  0·05  0·05 patient involved. Additional energy intake may be required for tissue repletion, especially during recovery from illness, and in individuals who are initially malnourished. Although the requirements of different patients vary widely, the principles of nutritional care remain very similar. Table 6 . Recommendations for the reporting of assessments of energy requirements in disease Ensure most, if not all, conditions of BMR measurements are fulfilled Report any deviations from strict conditions of BMR Report time of measurement, both with respect to time of day and course of the disease Document drug and feeding regimens regardless of whether measurement is taken free from thermic effects Take note of initial body composition of individual
